HHS Secretary Xavier Becerra (Michael Brochstein/Sipa USA/Sipa via AP Images)
HHS says Stelara may be deselected from Medicare negotiations, depending on biosimilar launch
Johnson & Johnson’s Stelara may not be on CMS’ Medicare negotiations list for long, HHS acknowledged in court documents filed last week.
The first 10 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
